Quinolinic acid in the pathogenesis of alzheimer's disease

Advances in Experimental Medicine and Biology

Volumn 527, Issue , 2003, Pages 167-176

  Guillemin, Gilles J ^a   Williams, Kieran R ^a   Smith, Danielle G ^a   Smythe, George A ^b   Croitoru Lamoury, Juliana ^c   Brew, Bruce J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1BETA; KYNURENIC ACID; PRION PROTEIN; QUINOLINIC ACID;

ALZHEIMER DISEASE; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MICROGLIA; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 1042291136     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0135-0_19     Document Type: Conference Paper

References (46)

1. H. Baran, K. Jellinger, L. Deecke, Kynurenine metabolism in Alzheimer's disease, J. Neural. Transm. 106, 165-181 (1999).
2. G.J. Guillemin, B.J. Brew, Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease (review), Redox Rep. in press (2002).
3. B. Widner, F. Leblhuber, J. Walli, G.P. Tilz, U. Demel, D. Fuchs, Tryptophan degradation and immune activation in Alzheimer's disease, J. Neural. Transm. 107, 343-353 (2000).
4. F. Moroni, Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites [In Process Citation], Eur. J. Pharmacol. 375, 87-100 (1999).
5. T.W. Stone, Neuropharmacology of quinolinic and kynurenic acids, Pharmacol. Rev. 45, 309-379 (1993).
6. I.P. Lapin, I.B. Prakhie, I.P. Kiseleva, Excitatory effects of kynurenine and its metabolites, amino acids and convulsants administered into brain ventricles: differences between rats and mice, J. Neural. Transm. 54, 229-238 (1982).
7. R. Schwarcz, W.O. Whetsell, Jr., R.M. Mangano, Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain, Science 219, 316-318 (1983).
8. M.G. Espey, O.N. Chemyshev, J.J. Reinhard, M.A. Namboodiri, C.A. Colton, Activated human microglia produce the excitotoxin quinolinic acid, Neuroreport 8, 431-434 (1997).
9. M.P. Heyes, C.L. Achim, C.A. Wiley, E.O. Major, K. Saito, S.P. Markey, Human microglia convert L-tryptophan into the neurotoxin quinolinic acid, Biochem. J. 320, 595-597 (1996).
10. M.P. Heyes, K. Saito, S.P. Markey, Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid, Biochem. J. 283, 633-635 (1992).
11. J. McLaurin, D. Yang, C.M. Yip, P.E. Fraser, Review: modulating factors in amyloid-beta fibril formation, J. Struct. Biol. 130, 259-270 (2000).
12. A. Delacourte, General and dramatic glial reaction in Alzheimer brains, Neurology 40, 33-37 (1990).
13. J.W. Unger, Glial reaction in aging and Alzheimer's disease, Microsc. Res. Tech. 43, 24-28 (1998).
14. R. Veerhuis, I. Janssen, C.J. De Groot, F.L. Van Muiswinkel, C.E. Hack, P. Eikelenboom, Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor, Exp. Neurol. 160, 289-299 (1999).
15. W.S. Griffin, J.G. Sheng, M.C. Royston, S.M. Gentleman, J.E. McKenzie, D.I. Graham, G.W. Roberts, R.E. Mrak, Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression, Brain Pathol. 8, 65-72 (1998).
16. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S. Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O'Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk, T. Wyss-Coray, Inflammation and Alzheimer's disease, Neurobiol. Aging 21, 383-421 (2000).
17. N.R. Cooper, B.M. Bradt, S. O'Barr, J.X. Yu, Focal inflammation in the brain: role in Alzheimer's disease, Immunol. Res. 21, 159-165 (2000).
18. Y.M. Arends, C. Duyckaerts, J.M. Rozemuller, P. Eikelenboom, J.J. Hauw, Microglia, amyloid and dementia in alzheimer disease. A correlative study, Neurobiol. Aging 21, 39-47 (2000).
19. R. Egensperger, S. Kosel, U. von Eitzen, M.B. Graeber, Microglial activation in Alzheimer disease: Association with APOE genotype, Brain Pathol. 8, 439-447 (1998).
20. M. Fiala, L. Zhang, X. Gan, B. Sherry, D. Taub, M.C. Graves, S. Hama, D. Way, M. Weinand, M. Witte, D. Lorton, Y.M. Kuo, A.E. Roher, Amyloid-beta induces chemokine secretion and monocyte migration across a human blood - brain barrier model, Mol. Med. 4, 480-489 (1998).
21. S.J. Kerr, P.J. Armati, L.A. Pemberton, G. Smythe, B. Tattam, B.J. Brew, Kynurenine pathway inhibition reduces toxicity of HIV-infected macrophages, Neurology 49, 1671-1681 (1997).
22. C.U. Kloss, G.W. Kreutzberg, G. Raivich, Proliferation of ramified microglia on an astrocyte monolayer: characterization of stimulatory and inhibitory cytokines, J. Neurosci. Res. 49, 248-254 (1997).
23. D. Giulian, T.J. Baker, Characterization of ameboid microglia isolated from developing mammalian brain, Journal of Neuroscience 6, 2163-2178 (1986).
24. G., Guillemin, F.D. Boussin, J. Croitoru, M. Franck-Duchenne, R. Le Grand, F. Lazarini, D. Dormont, Obtention and characterization of primary astrocyte and microglial cultures from adult monkey brains, J. Neurosci. Res. 49, 576-591 (1997).
25. G.J. Guillemin, J. Croitoru, D.G. Smith, D. Dormont, B.J. Brew, Quinolinic acid up-regulates chemokine production and chemokine receptor expression in astrocytes: implications for brain inflammation and AIDS, J. Neuroimmunol. 118, 119. A:361 (2001).
26. G.J. Guillemin, S.J. Kerr, G.A. Smythe, D.G. Smith, V. Kapoor, P.J. Armati, J. Croitoru, B.J. Brew, Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection, J. Neurochem. 78, 1-13 (2001).
27. C. Soto, E.M. Castano, The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis, Biochem. J. 314, 701-707 (1996).
28. H. Fukuda, T. Shimizu, M. Nakajima, H. Mori, T. Shirasawa, Synthesis, aggregation, and neurotoxicity of the Alzheimer's Abeta1-42 amyloid peptide and its isoaspartyl isomers, Bioorg. Med. Chem. Lett. 9, 953-956 (1999).
29. G.A. Smythe, S.J. Kerr, G.J. Guillemin, B. Brew, J. Quantification of picolinic acid using electron capture negative ion mass spectrometry, Anal. Biochem. submitted (1998).
30. M.P. Heyes, C.Y. Chen, E.O. Major, K. Saito, Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types, Biochem. J. 326, 351-356 (1997).
31. T.W. Stone, Endogenous neurotoxins from tryptophan, Toxicon 39, 61-73 (2001).
32. K.T. Akama, L.J. Van Eldik, Beta amyloid stimulation of inducible nitric oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism, J. Biol. Chem. 275, 7918-7924 (2000).
33. L. Meda, P. Baron, E. Prat, E. Scarpini, G. Scarlato, M.A. Cassatella, F. Rossi, Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35], J. Neuroimmunol. 93, 45-52 (1999).
34. J. Schiefer, R. Topper, W. Schmidt, F. Block, P.C. Heinrich, J. Noth, M. Schwarz, Expression of interleukin 6 in the rat striatum following stereotaxic injection of quinolinic acid, J. Neuroimmunol. 89, 168-176 (1998).
35. S.L. Yates, L.H. Burgess, J. Kocsis-Angle, J.M. Antal, M.D. Dority, P.B. Embury, A.M. Piotrkowski, K.R. Brunden, Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia, J. Neurochem. 74, 1017-1025 (2000).
36. V.C., Asensio, I.L. Campbell, Chemokines in the CNS: plurifunctional mediators in diverse states, Trends Neurosci. 22, 504-512 (1999).
37. M. Johnstone, A.J. Gearing, K.M. Miller, A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced, J. Neuroimmunol. 93, 182-193 (1999).
38. W. Kelder, J.C. McArthur, T. Nance-Sproson, D. McClemon, D.E. Griffin, Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia, Ann. Neurol. 44, 831-835 (1998).
39. M.Q. Xia, B.T. Hyman, Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease, J. Neurovirol. 5, 32-41 (1999).
40. K.A. Thompson, J.C. McArthur, S.L. Wesselingh, Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia, Ann. Neurol. 49, 745-752 (2001).
41. K. Kobayashi, M. Hayashi, H. Nakano, Y. Fukutani, K. Sasaki, M. Shimazaki, Y. Koshino, Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease, Neuropathol. Appl. Neurobiol. 28, 238-251 (2002).
42. W., Cammer, Oligodendrocyte killing by quinolinic acid in vitro, Brain Res. 896, 157-160 (2001).
43. F.V. Mena, P.J. Baab, C.L. Zielke, H.R. Zielke, In vivo glutamine hydrolysis in the formation of extracellular glutamate in the injured rat brain, J. Neurosci. Res. 60, 632-641 (2000).
44. A. Parpura-Gill, D. Beitz, E. Uemura, The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes, Brain Res. 754, 65-71 (1997).
45. R.G. Tavares, C.I. Tasca, C.E. Santos, M. Wajner, D.O. Souza, C.S. Dutra-Filho, Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain, Neuroreport 11, 249-253 (2000).
46. T.W. Stone, Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection, Trends Pharmacol. Sci. 21, 149-154 (2000).